2022
DOI: 10.14218/jcth.2022.00229
|View full text |Cite
|
Sign up to set email alerts
|

Therapeutic Use of Viruses: Newcastle Disease Virus HK84 Oncolytic Treatment for Hepatocellular Carcinoma

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
0
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 9 publications
0
0
0
Order By: Relevance
“…4 Although drugs like sorafenib are accessible, the five-year survival rate for patients with advanced liver cancer remains below 5%. 5,6 Consequently, it is crucial and of great significance to investigate novel treatment alternatives for HCC.…”
Section: Introductionmentioning
confidence: 99%
“…4 Although drugs like sorafenib are accessible, the five-year survival rate for patients with advanced liver cancer remains below 5%. 5,6 Consequently, it is crucial and of great significance to investigate novel treatment alternatives for HCC.…”
Section: Introductionmentioning
confidence: 99%